Clinical trial
An Open-Label, Randomized Clinical Study to Evaluate the Efficacy, Safety and Genetic Polymorphism of Hypoca(Barnidipine)and Adalat OROS(Nifedipine) in Mild to Moderate Hypertensive Patients
NCT00728858 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-Label, Randomized Clinical Study to Evaluate the Efficacy, Safety and Genetic Polymorphism of Hypoca(Barnidipine)and Adalat OROS(Nifedipine) in Mild to Moderate Hypertensive Patients
- Lead sponsor
- National Taiwan University Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2006
- Completion date
- February 28, 2007
- Enrollment
- 43 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.